Abstract Background -Pneumonia caused by infection with Streptococcus pneumoniae is still a major clinical problem. Reactive oxygen species contribute to the killing of these bacteria by polymorphonuclear leucocytes (PMNs). Defence mechanisms of Str pneumoniae which counter reactive oxygen species are characterised. Methods -PMNs were stimulated with phorbol myristate acetate (PMA) in the presence and absence of Str pneumoniae and supernatants from them, and superoxide (02 ) production was measured by the reduction of ferricytochrome c.
mechanisms of Str pneumoniae which counter reactive oxygen species are characterised. Methods -PMNs were stimulated with phorbol myristate acetate (PMA) in the presence and absence of Str pneumoniae and supernatants from them, and superoxide (02 ) production was measured by the reduction of ferricytochrome c.
Results -Streptococcus pneumoniae, but not Klebsiella pneumoniae or Staphylococcus aureus, inhibited PMA stimulated superoxide production by PMNs. Washed PMNs which had been preincubated with Str pneumoniae autolysis phase supernatants also exhibited depressed H202 production in response to PMA. The inhibitory activity was not attributable to non-specific cytotoxicity as assessed by release of the cytoplasmic enzyme lactate dehydrogenase, nor did the supernatants inhibit PMA stimulated degranulation of PMNs. Fractionation of the autolysis phase supernatants revealed inhibitory activity in both the fractions greater than and less than 10 kD. Like pneumolysin the inhibitory activity was heat sensitive. However, both a parent and pneumolysin negative mutant Str pneumoniae, and autolysis phase supernatants from them, inhibited PMN superoxide production.
Antisera to pneumolysin failed to abrogate the inhibitory effect of intact Str pneumoniae or autolysis phase supernatants from types 1 or 14 Strpneumoniae.
Conclusions -The inhibitory effect of Str pneumoniae on the respiratory burst of PMNs is not shared by two other common lung pathogens. The existence of a novel inhibitor of the PMN respiratory burst, distinct from pneumolysin, has been demonstrated. The inhibitor is specific for the respiratory burst and is active both in the logarithmic phase of growth and during autolysis. (Thorax 1994; 49:676-683) Despite antibiotics, infections caused by Streptococcus pneumoniae continue to cause a high morbidity and mortality. Pneumococcal pneumonia, for example, is the most common form of community acquired pneumonia in hospital' with an overall mortality of 5_13%,2 whilst meningitis caused by Str pneumoniae carries a mortality of 30%.' Furthermore, the worldwide increase in penicillin resistance and multiple antibiotic resistance among pneumococci,7 and the limited use of pneumococcal vaccine,8 suggest that pneumococcal infection may cause increasing morbidity and mortality in future years.
In the host's defence against Str pneumoniae killing by phagocytes has a key role. 
Effect of antipneumolysin serum on the ability of Str pneumoniae to inhibit the respiratory burst of PMNs Haemolytic assays: before examining the ability of antipneumolysin rabbit serum to reduce the inhibitory effect of Str pneumoniae on PMA stimulated PMN superoxide production it was necessary to determine the ability of the antipneumolysin serum to neutralise pneumolysin. The latter was tested by exploiting the ability of pneumolysin to lyse sheep red blood cells. Purified pneumolysin lysed sheep red blood cells at concentrations at or above 0-3ng/ml; antipneumolysin serum at 1:100 protected sheep red blood cells up to 5 ng/ml pneumolysin.
Additional experiments were set up to determine whether intact log phase Str pneumoniae and autolysis phase supematants produced pneumolysin as judged by their capacity to lyse sheep red blood cells. In three experiments log phase type 1 Str pneumoniae caused only slight haemolysis and neither normal rabbit serum nor antipneumolysin serum were protective (Str pneumoniae alone 8 5% (1 1%), Str pneumoniae+normal rabbit serum 799% (1 3%), Str pneumoniae+ antipneumolysin rabbit serum 6-5% (1-9%) haemolysis). In two of three experiments type 14 Str pneumoniae showed substantial haemolytic activity (66 4% and 87-3% haemolysis respectively). Normal rabbit serum partially protected the sheep red blood cells (28 1% and 19 9% haemolysis with normal rabbit serum present) and antipneumolysin rabbit serum protected further (8 0% and 8-3% haemolysis). The third type 14 sample had only a small lytic effect (9 3%); however, both normal rabbit serum and antipneumolysin rabbit serum completely blocked haemolysis (0%).
Ten autolysis supernatants (pH adjusted to 7T07-2) had very little lytic activity (2 2% (2-9%) haemolysis). These results also indicate that the inhibitory activity of Str pneumoniae is specific for the oxidative response and is not attributable to a non-specific toxic factor. Autolysis phase supernatants which inhibited the respiratory burst did not kill PMNs as assessed by LDH release -confirming our previous observations using trypan blue exclusion -nor did they inhibit the degranulation response of PMNs. Rather, the supernatants appeared synergistically to enhance PMA stimulated myeloperoxidase release. It is possible that the enhanced myeloperoxidase release is a consequence of the oxidative response inhibitor since myeloperoxidase is known to be inactivated by reactive oxygen species."4 Previous attempts'9 to determine how Str pneumoniae interferes with the PMN respiratory burst showed that, although the organism produces SOD, the amounts are insufficient to account for the interference observed. Thus, the interference is not due to a scavenging effect of SOD. Here it was shown that washed PMNs which had been preincubated with autolysis phase supernatants exhibited diminished production of hydrogen peroxide upon stimulation with PMA. This result also renders it unlikely that the interference is due to scavenging, but rather that it results from inhibition of the respiratory burst. Again this effect could not be attributed to death of the PMNs as they retained their viability as judged by trypan blue exclusion. The above results also show that the inhibitory effects are demonstrable using different assays for measuring the respiratory burst.
The ability of Str pneumoniae to inhibit the respiratory burst of PMNs may constitute a major counter defence of the microorganism and help to explain its pathogenicity. We therefore sought to characterise the inhibitory factor further. The results indicate that the activity is heat sensitive but that it is not inactivated by acidic conditions. Experiments using dialysed supernatants indicated that a fraction of molecular weight > 10 kD contained inhibitory activity. The loss of some activity on dialysis suggested the possibility of an additional low molecular weight inhibitor which is insensitive to catalase. Experiments using filtered supernatants, in which both the fractions > 10 kD and < 10 kD were retained, confirmed the presence of inhibitory activity in both fractions, in this instance more inhibitory activity being found in the fraction < 10 kD.
Some of the attributes of the inhibitory activity we 14 showed substantial haemolytic activity. Furthermore, autolysis phase supernatants were inhibitory despite the fact that they lacked haemolytic activity. A lack of haemolytic activity in itself suggests the absence of active pneumolysin. Such an outcome was not unexpected in the case of the autolysis phase supernatants because those used here were obtained from 18-24 hour cultures and were acidic (pH 5 3-6 4), and it is known that pneumolysin activity declines with prolonged Str pneumoniae culture (beyond 16 hours) due to increasing acidity. 28 Finally, in confirmation of the conclusion that the inhibitor described here is distinct from pneumolysin, antipneumolysin serum failed to abrogate the inhibitory effect of either log phase organisms or autolysis phase supernatants from Str pneumoniae despite its efficacy in neutralising pneumolysin in haemolytic assays.
It has been shown that pneumolysin inhibits oxidative responses.20 Our results suggest that the new inhibitor described here also contributes to the overall inhibitory effect of Str pneumoniae on the respiratory burst. Moreover, since pneumolysin is inactivated by the respiratory burst,'35 the inhibitor, by interfering with this process, may potentiate the activity of pneumolysin.
Our finding of haemolytic activity in log phase type 14 Str pneumoniae was surprising since extracellular pneumolysin activity has not previously been reported for log phase organisms. This may suggest that, although not released, pneumolysin is exposed on log phase type 14 Str pneumoniae. Alternatively, it is possible that the activity derives from a minority of organisms undergoing autolysis within the population and not from log phase organisms themselves.
In conclusion, these results demonstrate that Str pneumoniae produces a substance other than pneumolysin which inhibits the respiratory burst of PMNs. This substance is biologically active during the logarithmic phase of growth and is manifested by both clinically important and pneumolysin negative strains. 
